Cancer Types

Acute Lymphoblastic Leukemia

Aggressive cancer of lymphoid blood cells. Highly curable in pediatric patients; CAR-T therapy is transformative for relapsed/refractory cases.

Acute Myeloid Leukemia

Aggressive cancer of myeloid blood cells. Treatment based on risk stratification and increasingly on molecular markers (FLT3, IDH1/2, NPM1, TP53).

Adrenal Cancer

Anal Cancer

Aplastic Anemia

Beta Thalassemia

Inherited blood disorder causing reduced hemoglobin production. Treatment options include transfusion therapy, iron chelation, allogeneic stem cell transplant, and gene therapy (Casgevy, Zynteglo).

Bladder Cancer

Cancer of the bladder lining. Treatment ranges from BCG immunotherapy for non-muscle-invasive disease to systemic therapy for metastatic disease, including ADCs like enfortumab vedotin.

Brain Tumor

Tumors arising in the brain or central nervous system. Includes both primary tumors (gliomas, meningiomas, medulloblastomas) and metastases from other cancers.

Breast Cancer

Cancer that forms in breast tissue. Subtyped by hormone receptor (HR+/-), HER2 status, and tumor grade. The most common cancer among women globally.

Burkitt Lymphoma

Cancer of Unknown Primary

Metastatic cancer with no identifiable primary tumor site. Treatment guided by molecular profiling and tissue-of-origin testing.

Cervical Cancer

Cancer of the cervix, primarily caused by persistent HPV infection. Largely preventable through vaccination and screening.

Cholangiocarcinoma

Cancer of the bile ducts. Subtyped by location (intrahepatic, perihilar, distal). Increasingly treated with targeted therapy for FGFR2 fusions and IDH1 mutations.

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

BCR-ABL-driven leukemia. Treatment with TKIs (imatinib, dasatinib, nilotinib) has transformed CML into a manageable chronic disease.

Colon Cancer

Colorectal Cancer

Cancer of the colon or rectum. Often detected via screening colonoscopy. Treatment includes surgery, chemotherapy, targeted therapy, and immunotherapy for MSI-H tumors.

Diffuse Large B-Cell Lymphoma

Most common aggressive non-Hodgkin lymphoma. R-CHOP is standard first-line; CAR-T is approved for relapsed/refractory disease.

Endometrial Cancer

Esophageal Cancer

Cancer of the esophagus. Two main types: squamous cell carcinoma and adenocarcinoma. Treatment includes surgery, chemoradiation, immunotherapy, and HER2-targeted therapy.

Ewing Sarcoma

Rare bone and soft tissue sarcoma primarily affecting children and young adults. Treated with multi-agent chemotherapy plus local control.

Fanconi Anemia

Follicular Lymphoma

Gallbladder Cancer